Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

hemedic ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   9.6% 4.2% 2.2% 3.7% 4.6% 4.7% 10.6% 10.6%   Credit score (0-100)   27 49 65 50 46 44 23 23   Credit rating   BB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   853 653 753 613 727 2,176 0.0 0.0   EBITDA   446 159 226 -3.4 40.4 1,074 0.0 0.0   EBIT   446 159 207 -35.4 8.4 997 0.0 0.0   Pre-tax profit (PTP)   442.5 148.9 194.6 -64.3 -21.0 977.4 0.0 0.0   Net earnings   442.5 108.1 145.9 -56.1 -21.9 746.9 0.0 0.0   Pre-tax profit without non-rec. items   442 149 195 -64.3 -21.0 977 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 141 109 77.3 0.0 0.0 0.0   Shareholders equity total   460 568 714 658 636 1,383 1,333 1,333   Interest-bearing liabilities   254 260 317 370 980 1,797 0.0 0.0   Balance sheet total (assets)   2,447 1,046 1,370 1,637 1,972 3,885 1,333 1,333   Net Debt   -121 -624 -707 -574 121 -146 -1,333 -1,333     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   853 653 753 613 727 2,176 0.0 0.0   Gross profit growth   145.8% -23.4% 15.4% -18.6% 18.7% 199.1% -100.0% 0.0%   Employees   1 1 1 1 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,447 1,046 1,370 1,637 1,972 3,885 1,333 1,333   Balance sheet change%   371.4% -57.3% 31.0% 19.5% 20.5% 97.0% -65.7% 0.0%   Added value   445.7 158.7 226.1 -3.4 40.4 1,073.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 123 -64 -64 -155 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   52.3% 24.3% 27.6% -5.8% 1.2% 45.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.3% 9.6% 17.8% -2.2% 0.8% 34.3% 0.0% 0.0%   ROI %   90.3% 21.7% 23.0% -3.2% 1.1% 41.9% 0.0% 0.0%   ROE %   185.3% 21.0% 22.8% -8.2% -3.4% 74.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   32.2% 54.3% 52.1% 40.2% 32.2% 35.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -27.1% -393.0% -312.6% 17,083.3% 299.3% -13.6% 0.0% 0.0%   Gearing %   55.3% 45.8% 44.5% 56.2% 154.1% 129.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.9% 7.1% 6.9% 9.0% 5.2% 1.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.4 1.9 1.7 1.4 4.1 4.2 0.0 0.0   Current Ratio   1.2 2.2 1.9 1.6 5.2 5.5 0.0 0.0   Cash and cash equivalent   374.9 883.7 1,024.2 944.2 859.4 1,943.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   460.1 568.2 577.4 548.6 1,530.2 3,180.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   446 159 226 -3 20 537 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   446 159 226 -3 20 537 0 0   EBIT / employee   446 159 207 -35 4 498 0 0   Net earnings / employee   442 108 146 -56 -11 373 0 0